Valion Bio, Inc. (TIVC) Form 8-K — Jun 3, 2026
Valion Bio, Inc. (VBIO) reported the results of its 2026 Annual Meeting of Stockholders held on May 28, 2026. The primary agenda item was the approval of an amendment to the company’s 2021 Equity Incentive Plan, increasing the authorized share pool by 2,581,608 shares to a total of 3,219,566 shares. Stockholders also elected Dean Zikria as a Class II director and ratified the appointment of Rosenberg Rich Baker Berman, P.A.
Key figures
- Shares Outstanding
- 3139095
- Quorum Percentage
- 50
- Shares Added To Equity Plan
- 2581608
- Shares Previously Authorized
- 637958
- Shares Represented At Meeting
- 1569734
- Shares Authorized For Equity Plan
- 3219566
Price after filing
1 day: +16.3%7 days: +23.6%30 days: -22.7%
Close on the filing date to close N calendar days later (from $0.65). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.